Ropes & Gray

Ropes & Gray LLP is a global law firm with nine offices located in the United States, Asia, and Europe. The firm has over 1,000 lawyers and professionals worldwide, and its clients include corporations and financial institutions, government agencies, universities, and health care organizations. It was founded in 1865 in Boston, Massachusetts by John Codman Ropes and John Chipman Gray.

Source: Wikipedia

Campaign Finance

$142,232 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

covers through 2011

  • Top Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.

  • Republicans vs. Democrats

    in dollars

  • State vs. Federal

    in dollars

  • Top PAC Recipients

    Employee Color Block
    Individuals
    PAC Color Block
    PAC
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Ropes & Gray Sources: OpenSecrets.org FollowTheMoney.org

Lobbying

$220,000 Income
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers through Q3, 2011

Lobbying Carried Out by Ropes & Gray

View all lobbying data for Ropes & Gray Sources: Lobbyist Registration Tracker OpenSecrets.org

Regulations

10 Mentions
Information

All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.

Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.

Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.

Regulations and public comments can be downloaded in bulk here.

updated from Regulations.gov on September 27, 2011

The tables show occurrences of "Ropes & Gray" in public comments on proposed federal regulations.

  • Mentions in Document Text
    • Mentions
    • Agency
    • Docket
    • Date
    • Toggle 2 FDA Advisory Opinion regarding certain drug delivery device patents submitted for listing in the Orange Book under Section 505 of the Federal Food, Drug, and Cosmetic Act 2011
    • Toggle 1 SEC Exemptions for Advisers to Venture Capital Funds, Private Fund Advisers With Less Than $150 Million in Assets, etc. 2011
    • Toggle 1 FDA Establish Comprehensive, Clear and Binding Regulations to Guide The Industry Relating to New Uses of Marketed Drugs and Medical Devices 2011
    • Toggle 1 SEC Applications for Deregistration under Section 8(f) of the Investment Company Act of 1940 2011
    • Toggle 1 SEC Self-Regulatory Organizations; Proposed Rule Changes: Fixed Income Clearing Corp. 2011
    • Toggle 1 FDA Asking FDA to Adopt and Apply Specific Bioequivalence Requirements in its Review of Proposed Follow-on Version of RISPERDAL® CONSTA® 2011
    • Toggle 1 SEC Family Offices 2011
    • Toggle 1 SEC Applications: Highmark Funds and Highmark Capital Management, Inc. 2011
    • Toggle 1 OCC Margin and Capital Requirements for Covered Swap Entities 2011
    • Toggle 1 SEC Order of Suspension of Trading: Advanced Optics Electronics, Inc. 2011